Molecular mechanism of GANT61 combined with doxorubicin in the treatment of gliomas based on network pharmacology
Background: Gliomas are common malignant intracranial tumors. Efficacious targeted therapy against gliomas is lacking. Results: GANT61 combined with the chemotherapy drug doxorubicin for treatment of glioma (LN-229) cells, and the effect of their combination, was tested. The molecular mechanism was...
Saved in:
Main Authors: | Jing Chen, Qiang Zhang, Yuandong Zhuang, Shuang Liu, Xi Zhou, Guoliang Zhang |
---|---|
Format: | article |
Language: | EN |
Published: |
Elsevier
2022
|
Subjects: | |
Online Access: | https://doaj.org/article/8fc332733a374c25ae8bfd62375e3b0c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Size-dependent chemosensitization of doxorubicin-loaded polymeric nanoparticles for malignant glioma chemotherapy
by: Meng Gao, et al.
Published: (2021) -
Hybrid membrane-coated nanosuspensions for multi-modal anti-glioma therapy via drug and antigen delivery
by: Wenyan Hao, et al.
Published: (2021) -
Sevoflurane inhibits progression of glioma via regulating the HMMR antisense RNA 1/microRNA-7/cyclin dependent kinase 4 axis
by: Xi’an Bao, et al.
Published: (2021) -
Identification and validation of an autophagy-related signature for predicting survival in lower-grade glioma
by: Shaobin Feng, et al.
Published: (2021) -
Knockdown of long non-coding RNA AGAP2-AS1 suppresses the proliferation and metastasis of glioma by targeting microRNA-497-5p
by: Yi Sun, et al.
Published: (2021)